| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $13.57 ▲ +3.67% | Yesterday | $13.04 ▲ +0.38% | Tomorrow's Atrium Therapeutics Inc. Common Stock (RNA) setup is anchored to $13.09 and targets $13.57 (+3.67%). The near-term read is upside; watch $13.44 / $12.83 because daily realized volatility is about 2.82%. |
Tomorrow's Atrium Therapeutics Inc. Common Stock (RNA) setup is anchored to $13.09 and targets $13.57 (+3.67%). The near-term read is upside; watch $13.44 / $12.83 because daily realized volatility is about 2.82%. | ||||
| Week | $14.05 ▲ +7.33% | Last Week | $13.23 ▼ -1.06% | The 7-day Atrium Therapeutics Inc. Common Stock model moves from $13.23 to $14.05 (+7.33%). It gives upside momentum context for this stock, so breaks around $13.44 / $12.83 matter more than a single tick. |
The 7-day Atrium Therapeutics Inc. Common Stock model moves from $13.23 to $14.05 (+7.33%). It gives upside momentum context for this stock, so breaks around $13.44 / $12.83 matter more than a single tick. | ||||
| Month | $14.74 ▲ +12.61% | Last Month | $13.85 ▼ -5.49% | The 1-month Atrium Therapeutics Inc. Common Stock target is $14.74 (+12.61%), compared with the live reference near $13.09. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Atrium Therapeutics Inc. Common Stock target is $14.74 (+12.61%), compared with the live reference near $13.09. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $15.75 ▲ +20.32% | Last Year | $13.09 • 0.00% | The 1-year Atrium Therapeutics Inc. Common Stock scenario points to $15.75 (+20.32%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Atrium Therapeutics Inc. Common Stock scenario points to $15.75 (+20.32%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $18.11 ▲ +38.35% | 5 Years Ago | $14.75 ▼ -11.25% | The 5-year Atrium Therapeutics Inc. Common Stock view is $18.11 (+38.35%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Atrium Therapeutics Inc. Common Stock view is $18.11 (+38.35%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 38.0 | Bearish |
| MACD | 0.08 | Bullish |
| SMA 50 | $13.62 | Mid |
| SMA 200 | $13.71 | Mid |
| EMA 20 | $13.96 | Mid |
| Opening Price | $13.01 | Start Date | 2026-02-27 |
| Day Range | $12.98 – $13.28 | Market Cap | $2.10B |
| Monthly Range | $12.55 – $14.54 | 24h Volume | n/a |
| 90D Range | $12.32 – $16.54 | Circulating | n/a |
| 52W Range | $12.32 – $16.54 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.